Special Focus 1. 2. 3.
Gilbertsen VA, Nelms JM, The prevention of invasive cancer of the rectum, Cancer, 1978;41:1137–9.
Hardcastle JD, Farrands PA, Balfour TW, et al., Controlled trial of faecal occult blood testing in the detection of colorectal cancer, Lancet, 1983;2:1–4.
Hardcastle JD, Thomas WM, Chamberlain J, et al., Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects, Lancet, 1989;1:1160–4.
4.
Mandel JS, Bond JH, Church TR, et al., Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study, N Engl J Med, 1993;328:1365–71.
5. 6.
Hardcastle JD, Chamberlain JO, Robinson MH, et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer, Lancet, 1996;348:1472–7.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O, Randomised study of screening for colorectal cancer
with faecal-occult-blood test, Lancet, 1996;348:1467–71. 7. 8.
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM, Screening sigmoidoscopy and colorectal cancer mortality, J Natl Cancer Inst, 1992;84:1572–5.
Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS, A case-control study of screening sigmoidoscopy and mortality from colorectal cancer, N Engl J Med, 1992;326:653– 7.
9.
Hoff G, Grotmol T, Skovlund E, Bretthauer M, Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial, Br Med J, 2009;338:b1846.
10. Atkin WS, Edwards R, Kralj-Hans I, et al., Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial, Lancet, 2010;375:1624–33.
11. Baxter NN, Goldwasser MA, Paszat LF, et al., Association of colonoscopy and death from colorectal cancer, Ann Intern
Med, 2009;150:1–8.
12. Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN, Predictors of colorectal cancer after negative colonoscopy: a population-based study, Am J Gastroenterol, 2010;105:663– 73.
13. Brenner H, Hoffmeister M, Arndt V, et al., Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study, J Natl Cancer Inst, 2010;102:89–95.
14. Gryfe R, Kim H, Hsieh ET, et al., Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer, N Engl J Med, 2000;342:69–77.
15. Lieberman DA, Clinical practice. Screening for colorectal cancer, N Engl J Med, 2009;361:1179–87.
16. Macrae FA, St John DJ, Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas, Gastroenterology, 1982;82:891–8.
10
US GASTROENTEROLOGY & HEPATOLOGY REVIEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100